1. Procalcitonin – a new marker of severe infection and sepsis

   • K. Reinhart
   • J. Carlet

   EDITORIAL 01 March 2000 Pages: S145 - S145

2. A brief history of procalcitonin

   • C. Bohuon

   EDITORIAL 01 March 2000 Pages: S146 - S147

3. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock

   • F. M. Brunkhorst
   • K. Wegscheider
   • R. Brunkhorst

   ORIGINAL 01 March 2000 Pages: S148 - S152

4. Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients

   • C. Cheval
   • J. F. Timsit
   • J. Carlet

   ORIGINAL 01 March 2000 Pages: S153 - S158

5. The Clinical Value of Procalcitonin in the Prediction of Infected Necrois in Acute Pancreatitis

   • B. Rau
   • G. Steinbach
   • H. G. Beger

   ORIGINAL 01 March 2000 Pages: S159 - S164

6. Procalcitonin (PCT) in patients with abdominal sepsis

   • H. B. Reith
   • U. Mittelkötter
   • A. Thiede

   ORIGINAL 01 March 2000 Pages: S165 - S169

7. Discriminative power of inflammatory markers for prediction of tumor necrosis factor-α and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points

   • M. Oberhoffer
   • S. Rußwurm
   • K. Reinhart

   ORIGINAL 01 March 2000 Pages: S170 - S174

8. Procalcitonin as a marker of nosocomial infections in the neonatal intensive care unit

   • C. Chiesa
   • L. Pacifico
   • G. Mancuso

   ORIGINAL 01 March 2000 Pages: S175 - S177

9. Procalcitonin in pediatrics for differentiation of bacterial and viral infections

   • D. Gendrel
   • C. Bohuon

   ORIGINAL 01 March 2000 Pages: S178 - S181

10. Procalcitonin for differential diagnosis of graft rejection and infection in patients with heart and/or lung grafts

    • S. Hammer
    • F. Meisner
    • C. Hammer

    ORIGINAL 01 March 2000 Pages: S182 - S186

11. Procalcitonin – a new diagnostic tool in complications following liver transplantation

    • E.-R. Kuse
    • I. Langefeld
    • W.-R. Külpmann

    ORIGINAL 01 March 2000 Pages: S187 - S192

12. Procalcitonin in patients undergoing cardiopulmonary bypass in open heart surgery – first results of the Procalcitonin in Heart Surgery study (ProHearts)

    • M. Loebe
    • S. Locziewski
    • R. Hetzer

    ORIGINAL 01 March 2000 Pages: S193 - S198

13. Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection

    • R. Brunkhorst
    • O. K. Eberhardt
    • F. M. Brunkhorst

    ORIGINAL 01 March 2000 Pages: S199 - S201

14. Procalcitonin – a sensitive inflammation marker of febrile episodes in neutropenic children with cancer

    • G. Fleischhack
    • D. Cipic
    • U. Bode

    ORIGINAL 01 March 2000 Pages: S202 - S211

15. The natural elimination rate of procalcitonin in patients with normal and impaired renal function

    • M. Meisner
    • J. Schmidt
    • K. Tschaikowsky

    ORIGINAL 01 March 2000 Pages: S212 - S216